Knowledge Distillery

Limited information is available on incidence and outcomes of COVID-19 in patients with multiple sclerosis (MS). This study investigated the risks of…

This case-control study enrolled 58 COVID-19 positive and 62 COVID-19 negative patients, matched for age, gender and neurological admission causes,…

The B.1.617.2 (delta) variant of the SARS-CoV-2, the virus that causes Covid-19, has contributed to a surge in cases in India and has now been…

Because of concerns about thrombotic events after vaccination with ChAdOx1 nCoV-19 (Oxford–AstraZeneca), several European countries have recommended…

The impact of the COVID‐19 pandemic on PD patients is yet to be determined.

The authors conducted a longitudinal case-control 18F-FDG-PET study in patients diagnosed with COVID-19-related encephalopathy.

The effects of the COVID‐19 pandemic on telemedical care have not been described on a national level. Thus, the authors investigated the medical…

This nationwide study assessed the impact of the pandemic on stroke hospitalisation rates, patient characteristics, and 30‐day case fatality rates.

The objective of this matched cohort study was to establish whether there is any change in mortality from infection with a new variant of SARS-CoV-2 ,…

COVID-19 affects the nervous system in adult patients. The spectrum of neurologic involvement in children and adolescents is unclear. The objective …

Refinement of criteria for multisystem inflammatory syndrome in children (MIS-C) may inform efforts to improve health outcomes.

SARS-CoV-2 lineage B.1.1.7, a variant first detected in the UK in September 2020, has spread to multiple countries worldwide.